Ensign Peak Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.5M | Buy |
|
|||||
|
2025
Q2 | $26.7M | Buy |
|
|||||
|
2025
Q1 | $8.71M | Buy |
|
|||||
|
2024
Q4 | $5.36M | Sell |
|
|||||
|
2024
Q3 | $5.97M | Buy |
|
|||||
|
2024
Q2 | $4.53M | Sell |
|
|||||
|
2024
Q1 | $5.39M | Buy |
|
|||||
|
2023
Q4 | $3.65M | Buy |
|
|||||
|
2023
Q3 | $3.33M | Sell |
|
|||||
|
2023
Q2 | $25.9M | Sell |
|
|||||
|
2023
Q1 | $31.4M | Sell |
|
|||||
|
2022
Q4 | $45.2M | Buy |
|
|||||
|
2022
Q3 | $27.2M | Buy |
|
|||||
|
2022
Q2 | $4.12M | Buy |
|
|||||
|
2022
Q1 | $3.56M | Buy |
|
|||||
|
2021
Q4 | $2.03M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $104K | Sell |
|
|||||
|
2021
Q1 | $1.39M | Buy |
|
|||||
|
2020
Q4 | $578K | Buy |
|
|||||
|
2020
Q3 | $70K | Buy |
|